While many small pharma companies are racing to bring various coronavirus-related solutions to market, it is one of Big Pharma’s representatives that has flexed its muscles with the latest meaningful product. Last week, Abbott Laboratories (ABT) announced it had been granted emergency use authorization (EUA) by the FDA for its rapid COVID-19 antibody test, BinaxNOW.The test doesn’t need any instrumentation or equipment, and each test kit is completely disposable. The test provides results in 15 minutes, is priced at $5 and can be overseen by a wide range of people. Despite being a quick solution, it is highly accurate, with …read more
Source:: Yahoo Finance
